ANALYSIS OF THE POTENTIAL OF STREPTOCOCCUS SALIVARIUS ISOLATED FROM THE SALIVA AND TONGUE DORSUM TO INHIBIT THE GROWTH OF FUSOBACTERIUM NUCLEATUM

  • Azzara Nurfitri Department of Oral Biology, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia.
  • Hedijanti Joenoes Department of Oral Biology, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia.
  • Boy M Bachtiar Department of Oral Biology, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia.

Abstract

Objective: Analyzing the potential of S. salivarius isolated from the saliva and tongue dorsum of adults to inhibit the growth of Fusobacterium
nucleatum.
Methods: Polymerase chain reaction, deferred antagonism test, and well-diffused agar test.
Results: Inhibition of the growth F. nucleatum by S. salivarius isolated from the tongue dorsum (p>0.05). No inhibition to the growth of F. nucleatum
by S. salivarius isolated from the saliva. No inhibition to the growth of F. nucleatum by the protein produced by S. salivarius.
Conclusions: The growth of F. nucleatum was not inhibited by S. salivarius isolated from the saliva but by S. salivarius isolated from the dorsum of the
tongue.

Keywords: Streptococcus salivarius, Fusobacterium nucleatum, Probiotic.

References

1. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF,
Sumpradit N, et al. Antibiotic resistance - the need for global solutions.
Lancet Infect Dis 2013;13(12):1057-98.
2. Horz H, Meinelt A, Houben B, Conrads G. Distribution and persistence
of probiotic Streptococcus salivarius K12 in the human oral cavity as
determined by real-time quantitative polymerase chain reaction. Oral
Microbiol Immunol 2007;22(2):126-30.
3. Fauzi AA, Shafiei Z, Baharin B, Mohd N. Isolation of lactobacillus
from periodontally healthy subjects and its antimicrobial activity
against periodontal pathogens. Sains Malays 2013;42(1):19-24.
4. Burton JP, Wescombe PA, Macklaim JM, Chai MH, Macdonald K,
Hale JD, et al. Persistence of the oral probiotic Streptococcus salivarius
M18 is dose dependent and megaplasmid transfer can augment their
bacteriocin production and adhesion characteristics. PLoS One
2013;8(6):e65991.
5. Tamura S, Yonezawa H, Motegi M, Nakao R, Yoneda S, Watanabe H,
et al. Inhibiting effects of Streptococcus salivarius on competencestimulating
peptide-dependent biofilm formation by Streptococcus
mutans. Oral Microbiol Immunol 2009;24(2):152-61.
6. Kaci G, Goudercourt D, Dennin V, Pot B, Doré J, Ehrlich SD, et al.
Anti-inflammatory properties of Streptococcus salivarius, a commensal
bacterium of the oral cavity and digestive tract. Appl Environ Microbiol
2014;80(3):928-34.
7. Newman MG, Takei HH, Carranza FA. Carranza’s Clinical
Periodontology. 9th ed. St. Louis, Missouri: Elsevier Saunders; 2002.
8. Barbour A, Philip K. Variable characteristics of bacteriocin-producing
Streptococcus salivarius strains isolated from Malaysian subjects.
PLoS One 2014;9(6):e100541.
9. Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ. Inhibition
of propionibacterium acnes by bacteriocin-like inhibitory substances
(BLIS) produced by Streptococcus salivarius. J Drugs Dermatol
2006;5(9):868-70.
10. Wescombe PA, Upton M, Dierksen KP, Ragland NL, Sivabalan S,
Wirawan RE, et al. Production of the lantibiotic salivaricin A and its
variants by oral streptococci and use of a specific induction assay
to detect their presence in human saliva. Appl Environ Microbiol
2006;72(2):1459-66.
11. Prasad S, Morris PC, Hansen R, Meaden PG, Austin B. A novel
bacteriocin-like substance (BLIS) from a pathogenic strain of Vibrio
harveyi. Microbiology 2005;151(9):3051-8.
12. Ogawa A, Furukawa S, Fujita S, Mitobe J, Kawarai T, Narisawa N, et al.
Inhibition of Streptococcus mutans biofilm formation by Streptococcus
salivarius FruA. Appl Environ Microbiol 2011;77(5):1572-80.
13. Roger P, Delettre J, Bouix M, Béal C. Characterization of Streptococcus
salivarius growth and maintenance in artificial saliva. J Appl Microbiol
2011;111(3):631-41.
14. Brown L, Wolf JM, Prados-Rosales R, Casadevall A. Through the wall:
Extracellular vesicles in Gram-positive bacteria, mycobacteria and
fungi. Nat Rev Microbiol 2015;13(10):620-30.
15. Alakomi HL, Skyttä E, Saarela M, Mattila-Sandholm T, Latva‑Kala K,
Helander IM. Lactic acid permeabilizes gram-negative bacteria
by disrupting the outer membrane. Appl Environ Microbiol
2000;66(5):2001-5.
16. MacDonald KW. The Role of Streptococcus salivarius as a Modulator
of Homeostasis in the Oral Cavity. Electronic Thesis and Dissertation
Repository. University of Western Ontario; 2015.
17. Barbour A, Tagg J, Abou-Zied OK, Philip K. New insights into the
mode of action of the lantibiotic salivaricin B. Sci Rep 2016;6:31749.
18. Weerkamp AH, McBride BC. Adherence of Streptococcus salivarius
HB and HB-7 to oral surfaces and saliva-coated hydroxyapatite. Infect
Immun 1980;30(1):150-8.
19. Barbour A, Philip K, Muniandy S. Enhanced production,
purification, characterization and mechanism of action of salivaricin
9 lantibiotic produced by Streptococcus salivarius NU10. PLoS One
2013;8(10):e77751.
20. Draper LA, Cotter PD, Hill C, Ross RP. The two peptide lantibiotic
lacticin 3147 acts synergistically with polymyxin to inhibit Gram
negative bacteria. BMC Microbiol 2013;13:212.
21. Brötz H, Sahl HG. New insights into the mechanism of action of
lantibiotics - Diverse biological effects by binding to the same
molecular target. J Antimicrob Chemother 2000;46(1):1-6.
Statistics
173 Views | 175 Downloads
How to Cite
Nurfitri, A., Joenoes, H., & Bachtiar, B. (2017). ANALYSIS OF THE POTENTIAL OF STREPTOCOCCUS SALIVARIUS ISOLATED FROM THE SALIVA AND TONGUE DORSUM TO INHIBIT THE GROWTH OF FUSOBACTERIUM NUCLEATUM. International Journal of Applied Pharmaceutics, 9, 8-12. https://doi.org/10.22159/ijap.2017.v9s1.06
Section
Original Article(s)